Molecular and cellular organization of the central nervous system: implications for new therapeutics.
Waxman
S G
SG
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D001927:Brain Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D009474:Neurons / Q000378:metabolism / Q000502:physiology; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology; D013116:Spinal Cord / Q000378:metabolism / Q000502:physiology; D013118:Spinal Cord Diseases / Q000188:drug therapy* / Q000503:physiopathology*
D017981:Receptors, Neurotransmitter